Innovative approaches to managing pediatric hematologic malignancies: clinical and translational perspectives
Keywords:
Pediatric hematology, Hematologic malignancies, Precision medicine, Gene therapy, Translational researchAbstract
Pediatric hematologic malignancies, encompassing acute leukemias, lymphomas, and rare myelodysplastic syndromes, remain a leading cause of childhood morbidity and mortality worldwide. Over the past decade, rapid advancements in molecular biology, immunotherapy, and gene-editing technologies have revolutionized diagnostic, prognostic, and therapeutic strategies. This narrative review explores innovative clinical and translational approaches in pediatric hematologic malignancies, highlighting precision medicine, novel pharmacologic interventions, immunotherapeutic modalities, and integrative strategies that bridge laboratory discoveries to bedside care. Emphasis is placed on recent breakthroughs in chimeric antigen receptor (CAR) T-cell therapy, targeted small-molecule inhibitors, and gene therapy, as well as challenges in implementation, including accessibility, safety, and long-term outcomes. By synthesizing current evidence, this review provides a framework for clinicians and researchers seeking to optimize patient-centered care and accelerate translational progress in pediatric hematology.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 The African Journal of Perinatology

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
